Literature DB >> 17367835

How adenovirus strives to control cellular gene expression.

Hongxing Zhao1, Fredrik Granberg, Ulf Pettersson.   

Abstract

Host cell gene expression during the course of a human adenovirus infection in synchronized primary human lung fibroblasts was analyzed using cDNA microarrays. The slow progression of the infectious cycle in these cells allowed a detailed examination of cellular gene regulation. In total, 988 unique genes were identified as differentially expressed more than 2-fold. The cellular gene expression profiles closely correlated to the progression of the infection. Based on the observed expression patterns, the deregulation of cellular genes' expression could be separated into four periods: (i) the immediate response of the host to incoming virus; (ii) deregulation of cellular genes involved in cell cycle, growth control, and antiviral response; (iii) steady-state regulation of cellular gene expression during viral DNA replication; (iv) targeting of cellular genes involved in intra- and extra-cellular structure at the late phase of infection. The struggle of the virus to gain control of TGF-beta and Wnt signaling, as well as the apoptotic pathways, was conspicuous.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367835     DOI: 10.1016/j.virol.2007.02.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription.

Authors:  Daniel L Miller; Brenden Rickards; Michael Mashiba; Wenying Huang; S J Flint
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

2.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

3.  Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle.

Authors:  Sayuri E M Kato; Wenying Huang; S J Flint
Journal:  Virology       Date:  2011-05-24       Impact factor: 3.616

4.  Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells.

Authors:  Mallory A Turner; Sumit Middha; Sean E Hofherr; Michael A Barry
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

5.  Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  Virus Res       Date:  2009-10-23       Impact factor: 3.303

6.  Adenovirus E4orf4 protein downregulates MYC expression through interaction with the PP2A-B55 subunit.

Authors:  Haggit Ben-Israel; Rakefet Sharf; Gideon Rechavi; Tamar Kleinberger
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

7.  Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis.

Authors:  Dominik E Dorer; Frank Holtrup; Kurt Fellenberg; Johanna K Kaufmann; Sarah Engelhardt; Jörg D Hoheisel; Dirk M Nettelbeck
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

8.  Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters.

Authors:  Baoling Ying; Karoly Toth; Jacqueline F Spencer; Rajeev Aurora; William S M Wold
Journal:  Virology       Date:  2015-08-28       Impact factor: 3.616

9.  Limited but durable changes to cellular gene expression in a model of latent adenovirus infection are reflected in childhood leukemic cell lines.

Authors:  D A Ornelles; L R Gooding; M L Dickherber; M Policard; C Garnett-Benson
Journal:  Virology       Date:  2016-04-14       Impact factor: 3.616

10.  Data on the expression of cellular lncRNAs in human adenovirus infected cells.

Authors:  Maoshan Chen; Hongxing Zhao; Sara Bergström Lind; Ulf Pettersson
Journal:  Data Brief       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.